These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 32210089)
1. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease. Patel DM; Bose M; Cooper ME Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089 [TBL] [Abstract][Full Text] [Related]
2. Update of pathophysiology and management of diabetic kidney disease. Lin YC; Chang YH; Yang SY; Wu KD; Chu TS J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908 [TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy: where hemodynamics meets metabolism. Forbes JM; Fukami K; Cooper ME Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765 [TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Warren AM; Knudsen ST; Cooper ME Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867 [No Abstract] [Full Text] [Related]
5. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease. Zou H; Zhou B; Xu G Cardiovasc Diabetol; 2017 May; 16(1):65. PubMed ID: 28511711 [TBL] [Abstract][Full Text] [Related]
6. Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Sugahara M; Pak WLW; Tanaka T; Tang SCW; Nangaku M Nephrology (Carlton); 2021 Jun; 26(6):491-500. PubMed ID: 33550672 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis. Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754 [TBL] [Abstract][Full Text] [Related]